Level Biotechnology, Inc. engages in the provision of biotechnological services. It offers the following business activities: biomedical access products, and preclinical testing service businesses. Its Biomedical Access Products business offers cell culture, immune protein, gene nucleic acids and molecular biology, and instruments and equipment for biomedical research units, hospitals, and biotechnology companies. Its Preclinical Testing Service business provides genetic toxicity, general toxicology, reproductive toxicology, pharmacokinetics, biocompatibility, and heath food safety testing services. The company was founded on December 7, 1989 and is headquartered in New Taipei, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company